Related Experiment Video
Updated: Mar 22, 2026
07:25
Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans
Published on: December 9, 2022
2.1K
Longevity-Promoting Pharmaceuticals: Is it a Time for Implementation?
Alexander M Vaiserman1, Francesco Marotta2
1Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine.
Trends in Pharmacological Sciences
|April 27, 2016
Summary
Experimental studies show that targeting aging with medications like antioxidants can promote health and extend lifespan. These anti-aging drugs offer a promising approach to preventing age-related diseases.
Area of Science:
- Gerontology and Longevity Science
- Pharmacology
- Biomedical Research
Background:
- Aging is a complex biological process associated with numerous pathologies.
- Current treatments often focus on individual age-related diseases.
- Emerging research suggests a more unified approach to aging is possible.
Purpose of the Study:
- To review the efficacy of pharmacological interventions targeting the aging process.
- To compare the effectiveness of anti-aging strategies with disease-specific treatments.
- To highlight the therapeutic and industrial potential of anti-aging drug development.
Main Methods:
- Review of recent experimental studies on aging interventions.
- Analysis of data on healthspan and lifespan extension.
- Comparative assessment of aging-targeted versus pathology-targeted treatments.
Main Results:
- Medications targeting aging (e.g., antioxidants, calorie restriction mimetics, autophagy inductors) significantly promote health and extend lifespan.
- Pharmacological targeting of aging demonstrates superior efficacy in preventing age-related pathology compared to treatments for specific diseases.
- Development of novel anti-aging drugs presents significant opportunities for the pharmaceutical and healthcare sectors.
Conclusions:
- Targeting the fundamental mechanisms of aging offers a powerful strategy for improving health and longevity.
- Anti-aging pharmacotherapy represents a paradigm shift from treating symptoms to addressing root causes of age-related decline.
- The pharmaceutical industry stands to benefit from the development and commercialization of effective anti-aging interventions.
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
304
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
304
01:26Oral Drug Delivery Systems: Continuous-Release Systems
184
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
184
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
83
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
83
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
797
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
797
01:30Prodrugs
4.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.6K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
236
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
236